Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of HTD1801 versus dapagliflozin in type 2 diabetes inadequately controlled on metformin
CTR20240991Phase 3Completed
- Sponsor
- Juntesun Bioscience
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of berberine ursodeoxycholate in type 2 diabetes mellitus (T2DM), sponsored by Juntesun Bioscience. Started Mar 2024; status: completed.
02
Drugs
berberine ursodeoxycholate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20240991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240991.